课题基金 / 基金详情

Project #3: Fibrillogenesis Mediated Phenotype Switching of Breast Cancer Cells

Project #3: Fibrillogenesis Mediated Phenotype Switching of Breast Cancer Cells
项目
批准号:
9449733
负责人:
Archana Varadaraj
金额:
$22.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Archana Varadaraj的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Epithelial-stromal interactions are critical determinants of epithelial cell behavior in a tumor. While the stromal microenvironment and alterations in the stromal extracellular matrix (ECM), influences invasive and migratory properties at the invasive front, the role of the epithelial matrix in influencing cancer cell behavior are less well understood. Extracellular matrix (ECM) perturbations in epithelial cancers contribute to metastatic spread accounting for 80% of the cancer-related deaths worldwide. The molecular cues that affect the ECM and precede stromal influences on epithelial cell metastasis, is a critical first step at identifying pathways that can be molecularly targeted in the future. The overarching goal of this project is to determine whether alterations in the extracellular matrix of cancer epithelial cells can sufficiently alter cancer cell invasion, migration and metastatic propensity. Fibronectin (FN) matrix dysregulation in response to hypoxia using hypoxia mimetics and 1% O2 will be investigated in the MCF10A progression series to determine whether cellular responses in the three cell lines alternate between premalignant and malignant phenotypes or preinvasive and invasive phenotypes. During low O2 levels in the cells, Hypoxia-inducible factor (HIF)-1α and HIF2α proteins undergo stabilization and translocate to the nucleus to enable transcription of genes involved in cell survival, angiogenesis, and metabolism. An angiogenic transcriptional target of HIFα is VEGF (Vascular endothelial growth factor), which interacts with the C-terminal Heparin-II domain of the FN protein. Using non-contacting and contacting transwell assays, with endothelial cells, the role of FN fibrillogenesis in binding VEGF or releasing VEGF to promote angiogenesis will be determined. While breast cell lines are used in this study, the project goal applies to epithelial cancer cell invasion and migration and hypoxia- mediated angiogenesis that depend on FN fibrillogenesis. The long-term goal of this study is to provide new information on unfavorable FN matrix changes that can be perhaps stabilized that in combination with existing therapeutic strategies will help alleviate cancer cell aggression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SOCS domain-mediated fibronectin matrix degradation on fibrosis reversal
  • 批准号:
    10292074
  • 项目类别:
  • 资助金额:
    $46.9万
  • 财政年份:
    2021
  • 负责人:
    Archana Varadaraj
  • 依托单位:
海外基金